NorthX Climate Tech used its Converge 2025 conference this week to announce $2 million in new funding aimed at speeding up the growth of British Columbia’s climate-tech sector.
The announcement, delivered by CEO Sarah Goodman during opening remarks, includes $500,000 in seed capital for five BC university-linked ventures: Carbonyx, Cura Climate, Green Manganese, Narval Energy, and PhyCo. Each will receive $100,000 to strengthen early product development and validate core technology.
NorthX also made a $1.5 million follow-on investment in Mangrove Lithium, reinforcing its support for one of BC’s most advanced climate-tech scaleups.
The new capital will help Mangrove demonstrate continuous operation of its electrochemical lithium-refining system — the final technical milestone before commercial deployment. The company’s low-carbon refining process is positioned to support reshoring of North America’s critical battery materials supply chain.
Goodman said the announcement reflects NorthX’s mission to close the “translation gap” holding back climate hard-tech innovation.
“Every major climate tech solution begins with a spark,” she said. “NorthX exists to back the builders turning ideas into industry with capital, connections, and conviction.”
NorthX is now Canada’s largest funder of post-secondary climate ventures, with more than $17 million invested in university spinouts. Its overall portfolio includes nearly $50 million across 80 projects, supporting 900 jobs and catalyzing nearly half a billion dollars in follow-on investment.
The five newly funded ventures highlight BC’s growing edge in climate hard tech:
• Carbonyx (UBC): CO₂-based industrial minerals
• Cura Climate (UBC): Cutting cement emissions by up to 85%
• Green Manganese (BCIT): Clean extraction of battery-grade manganese
• Narval Energy (UBC): Sodium-based batteries for extreme cold
• PhyCo (SFU): Compostable bioplastics from seaweed and waste
With this week’s investments, NorthX continues to anchor BC’s climate-tech ecosystem at both the lab and scaleup stages — a strategy the organization says is essential for turning research breakthroughs into commercial impact.
Leave a Reply